Glenmark Pharmaceuticals Ltd. posted a net profit after tax of Rs 52.200 million for the quarter ended June 30, 2009
The Company has posted a net profit after tax of Rs 52.200 million for the quarter ended June 30, 2009 as compared to Rs 568.357 million for the quarter ended June 30, 2008. Total Income has increased from Rs 1944.176 million for the quarter ended June 30, 2008 to Rs 2219.753 million for the quarter ended June 30, 2009.
The Consolidated Results are as follows
The Group has posted a net profit after tax of Rs 534.546 million for the quarter ended June 30, 2009 as compared to Rs 1153.768 million for the quarter ended June 30, 2008. Total Income has increased from Rs 4717.417 million for the quarter ended June 30, 2008 to Rs 5512.800 million for the quarter ended June 30, 2009.
